Achaogen Stock

Achaogen Buyback Yield

Delisted

Buyback Yield of Achaogen (AKAOQ) as of Aug 13, 2026.

Buyback Yield

0.00

Last updated:

Buyback Yield of Achaogen is 2026 0.00 . Buyback Yield of Achaogen was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Achaogen Stock analysis

What does Achaogen do? Achaogen Inc is an innovative biotechnology company specializing in the development of antibiotics for the treatment of life-threatening infectious diseases. The company's business model is based on research and development of new antibiotics, aiming to improve medical care for patients with infections. Achaogen was founded in 2002 by a team of researchers and professionals in the biotechnology industry and has developed several products for the treatment of diseases such as pneumonia, urinary tract infections, and bloodstream infections. The company's main divisions include Plazomicin, Zemdri, and C-Scape, which are antibiotics targeting different types of infections. Achaogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Achaogen stock

On Eulerpool you can find the complete historical development of Buyback Yield Achaogen since 2006 – with annual values, charts, and detailed analysis.

Buyback yield measures the percentage of market cap returned to shareholders through share repurchases. It complements dividend yield in assessing total shareholder returns.

To evaluate Buyback Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Buyback Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Buyback Yield's Achaogen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Achaogen

All Key Metrics — Achaogen